Venture Visionary Partners LLC Gilead Sciences, Inc. Transaction History

Venture Visionary Partners LLC

$2.25 Billion
Q3 2024

A detailed history of Venture Visionary Partners LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Venture Visionary Partners LLC holds 7,705 shares of GILD stock, worth $707,935. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,705

Previous 8,388 8.14%

Holding current value

$707,935

Previous $575,000 12.17%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$66.59 - $83.99 $45,480 - $57,365	-683 Reduced 8.14%	7,705 $645,000
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $61,066 - $70,474	967 Added 13.03%	8,388 $575,000
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $4,939 - $6,023	69 Added 0.94%	7,421 $543,000
Q4 2023 Feb 15, 2024	BUY	$73.27 - $83.09 $1,611 - $1,827	22 Added 0.3%	7,352 $595,000
Q4 2023 Jan 24, 2024	BUY	$73.27 - $83.09 $22,786 - $25,840	311 Added 4.43%	7,330 $593,000
Q3 2023 Oct 13, 2023	SELL	$73.94 - $80.67 $35,195 - $38,398	-476 Reduced 6.35%	7,019 $526,000
Q2 2023 Jul 14, 2023	SELL	$76.01 - $86.7 $22,422 - $25,576	-295 Reduced 3.79%	7,495 $577,000
Q1 2023 Apr 13, 2023	SELL	$77.31 - $88.08 $29,377 - $33,470	-380 Reduced 4.65%	7,790 $646,000
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $25,613 - $36,772	-411 Reduced 4.79%	8,170 $701,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.55 Million - $1.77 Million	-26,032 Reduced 75.21%	8,581 $529,000
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $507,185 - $571,242	-8,787 Reduced 20.25%	34,613 $2.14 Million
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $346,014 - $433,592	-5,974 Reduced 12.1%	43,400 $2.58 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $188,346 - $213,776	2,903 Added 6.25%	49,374 $3.62 Million
Q3 2021 Oct 20, 2021	BUY	$67.69 - $73.03 $462,119 - $498,575	6,827 Added 17.22%	46,471 $3.27 Million
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $1.36 Million - $1.48 Million	21,362 Added 116.85%	39,644 $2.79 Million
Q1 2021 Apr 27, 2021	BUY	$60.0 - $68.46 $678,660 - $774,351	11,311 Added 162.26%	18,282 $1.18 Million
Q4 2020 Jan 27, 2021	BUY	$56.65 - $64.55 $394,907 - $449,978	6,971 New	6,971 $406,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.

Account

Venture Visionary Partners LLC Gilead Sciences, Inc. Transaction History